CIK 0001623526 · Non-accelerated filer<br>Smaller reporting company
Stoke Therapeutics, Inc.
Sign in to watch- Ticker
- STOK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471144582
- Phone
- 781-430-8200
- Business address
- 45 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ASOthera Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,050,832
- in 7 filings, $404K under 10b5-1 plans
Net −$1,050,832. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-02 | Ticho Barry CHIEF MEDICAL OFFICER | Sale 10b5-1 | −5,501 | $19.87 | $109K | 18,469 |
| 2025-09-02 | Kaye Edward M. MD Director | Sale 10b5-1 | −14,860 | $20.14 | $299K | 137,581 |
| 2025-09-02 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Option exercise 10b5-1 | +9,150 | $7.07 | $65K | 33,098 |
| 2025-09-02 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale 10b5-1 | −14,922 | $20.14 | $300K | 18,176 |
| 2025-09-02 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Option exercise · Stock Option (Right to Buy) 10b5-1 | −9,150 | 15,801 | ||
| 2025-08-29 | Kaye Edward M. MD Director | Sale 10b5-1 | −1,029 | $20.00 | $21K | 152,441 |
| 2025-08-29 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Option exercise 10b5-1 | +850 | $7.07 | $6K | 24,798 |
| 2025-08-29 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale 10b5-1 | −850 | $20.00 | $17K | 23,948 |
| 2025-08-29 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Option exercise · Stock Option (Right to Buy) 10b5-1 | −850 | 24,951 | ||
| 2025-08-18 | Ticho Barry CHIEF MEDICAL OFFICER | Sale | −2,805 | $18.24 | $51K | 23,970 |
| 2025-08-18 | Kaye Edward M. MD Director | Sale | −12,126 | $18.24 | $221K | 153,470 |
| 2025-08-18 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale | −1,683 | $18.24 | $31K | 23,948 |
| 2025-08-14 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise | +10,000 | 26,775 | ||
| 2025-08-14 | Ticho Barry CHIEF MEDICAL OFFICER | Grant or award · Performance Stock Units | +20,000 | 20,000 | ||
| 2025-08-14 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise · Performance Stock Units | −10,000 | 10,000 | ||
| 2025-08-14 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Option exercise | +6,000 | 25,631 | ||
| 2025-08-14 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Grant or award · Performance Stock Units | +12,000 | 12,000 | ||
| 2025-08-14 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Option exercise · Performance Stock Units | −6,000 | 6,000 | ||
| 2025-08-14 | Kaye Edward M. MD Director | Option exercise | +26,250 | 165,596 | ||
| 2025-08-14 | Kaye Edward M. MD Director | Grant or award · Performance Stock Units | +52,500 | 52,500 |
Page 10 of 13 · 256 trades